MedPath

Cefmetazole

Generic Name
Cefmetazole
Drug Type
Small Molecule
Chemical Formula
C15H17N7O5S3
CAS Number
56796-20-4
Unique Ingredient Identifier
3J962UJT8H
Background

A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.

Indication

For the treatment of infections caused by susceptible organisms.

Associated Conditions
Susceptible Bacterial Infections
Clinical Trials
Related News

Retrograde Intrarenal Surgery Low Risk Trial

Phase 4
Conditions
Retrograde Intrarenal Surgery
Renal Stones
Interventions
First Posted Date
2024-12-19
Last Posted Date
2024-12-19
Lead Sponsor
National Taiwan University Hospital
Target Recruit Count
200
Registration Number
NCT06741917
Locations
🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic Antibiotics

Phase 3
Completed
Conditions
Colorectal Neoplasms
Interventions
Drug: kanamycin/metronidazole
First Posted Date
2007-07-30
Last Posted Date
2012-09-19
Lead Sponsor
Japan Multinational Trial Organization
Target Recruit Count
584
Registration Number
NCT00508690
Locations
🇯🇵

Tenriyorozu Hospital, Tenri, Nara, Japan

🇯🇵

National Hospital Organization, Kyoto Medical Center, Kyoto, Japan

🇯🇵

Kyoto Katsura Hospital, Kyoto, Japan

and more 2 locations

Trial of Antibiotic Prophylaxis in Elective Colorectal Surgery

Phase 3
Completed
Conditions
Colorectal Surgery
First Posted Date
2006-02-16
Last Posted Date
2006-02-16
Lead Sponsor
National Cancer Center, Japan
Target Recruit Count
500
Registration Number
NCT00292708
Locations
🇯🇵

Nagoya Medical Center, Nagoya, Japan

🇯🇵

Niigata Cancer Center Hospital, Niigata, Japan

🇯🇵

National Cancer Center Hospital, Tokyo, Japan

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy